Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
cs analysis just posted. Sequenom Inc. (Nasdaq: SQNM) is seeing interest late in the session on positive chatter related to research and development news on its Trisomy 21 (Down syndrome) test. Shares up 8.7% in afternoon action.
roger that - jumpy now.
Interesting day. Look forward to next week.
orrv running today
If you liked CVM at 1.88 and 1.47, you're going to love it at 1.13. I think I saw that on Netflix.
Looks like my restriction was lifted. Not that I have much but I have all my orrv shares in one place now.
1K of mine were in there - happy to have some freebees in my account now with profit. What's going on here? I like it!
Can we sell any?
Anyone on Lehmans? I have some LEHCQ and all of them are moving on news from over the weekend.
I am glad I picked up more at 3.4 yesterday. Now the question is what to do next time it hits 5. I still think this is 10-15 or more again once the dust settles in a year or so.
I've been offering some 9s and now that we're at 9 I wonder who got the fill? Mine are still out there.
movement today. Good sign.
I think tomorrow a.m. it will run and late afternoon sell off. Next week will be a good one as people will begin to download the app in masses over the weekend through word of mouth that it's finally happenned. This was percieved as old news to some that I spoke with but now that it's a reality, the buzz should pick up.
Used Bing and got this from Boston Globe
'use Bing so my MSFT shares go up and SIRI will go up on interest too'
http://www.boston.com/business/technology/articles/2009/06/18/sirius_xm_unveils_iphone_ipod_touch_app/
Just came over from the 5 bagger board. This has crazy volume and spikes for a low priced stock.
I tried to grab some 001's yesterday, didn't get filled, and backed out. Missed that near double up yesterday. Is anyone unloading restricted's yet? It's June 09.
I tried to sell 1000 at .1 and 1500 at .08 a couple of times this week. no fill.
NCS missed by 1 cent so it depends how sensitive people are.
Pre-market flippin going on. Hope it's steady rise with the market predicted up today.
Still have CDIV - hope the shake down at .012-.013 is done.
SQNM was a big run yesterday - hoping for more today.
even on ncs - wonder if I should get out.
Bottle Rocket today! This came quick.
Profitrade - Call Tomorrow for NCS see link http://finance.yahoo.com/news/NCI-Building-Systems-Second-prnews-15282720.html?.v=4
Grabbed some of those .003 CDIV's. Been tempted for a few weeks. Hope to ride a big wave!
Trying some of that NCS. Where do you see it coming back to? Will the earnings announcement be decent?
Good to see the blog back and active. Life was a little more interesting when that was going full force.
trying to get rid of 1000
I like the mojo here. This will run soon!
Can anyone sell? I am trying again today. 3rd time the charm?
Great News - $4 pre-market. New high coming today!
http://finance.yahoo.com/news/Delcath-Systems-Granted-Third-prnews-15410140.html?.v=1
put a sell bid out there for 1000 this am. but the 10000 went and mine is still out there. At least there is continued interest in this one this week.
OK better for the environment then.
Just noticed it in my acct. PARADIGM TACTICAL PROXXX1 FOR 75 REVERSE SPLIT EFF 05/29/09
They going to be restricted at all? More paper worth less than the paper right now.
Phase III
Phase III trials are generally the last stop on a drug's way from the lab to the pharmacy. These trials involve large subject groups and are designed to be the final assessment of a drug's efficacy and side effects. Phase III trials go one step further by comparing the drug candidate to the current standard treatment for a particular condition. If a drug is effective but shows no significant benefits over a treatment already in use, it can still be approved for production, though sales might not be as high as its developer had hoped. In the news, a drug that is proven to be safe and effective but that doesn't offer any advantages over the current "gold standard" treatment is often said to have "failed" the Phase III trials. While this something of a misnomer, it reflects the importance for pharmaceutical companies to develop innovative drugs that improve on existing treatment options.
Phase IV
Phase IV clinical trials occur after the approval and release of a new drug. These trials, which are sometimes not required, are used to further understand a drug's mechanism of action. For example, Phase IV trials often test the drug's interactions with other drugs and its effectiveness in certain populations that were not present in previous clinical trials. Additionally, drugs in this phase are monitored for long-term side effects that clinical trials were unable to detect. This can be important, since the relatively short duration of the clinical testing process doesn't allow for the observance of a drug's long-term impact on subjects. Vioxx, the blockbuster osteoarthritis drug made by Merck (MRK), is a well-known example of a drug recalled as a result of continual monitoring for safety.
Retrieved from "http://www.wikinvest.com/concept/Clinical_trials"
I think they need to finish Phase III to get that go-ahead, but they way it's going Phase III is pretty solid from what I read.
.1 today! hope .05 is the new level before the boom!
KOMANDO - AMNE - great call - I did but ducked out ahead of the big jump.
Did you get the AHR? It's up big pre-market!